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The role which West and Central African wildlife populations might play in the transmission dynamics of FMD is not
known nor have studies been performed in order to assess the distribution and prevalence of FMD in wild animal species
inhabiting those specific regions of Africa. This study reports the FMD serological profile extracted from samples (n = 696)
collected from wildlife of West and Central Africa between 1999 and 2003. An overall prevalence of FMDV NSP reactive
sera of 31.0% (216/696) was estimated, where a significant difference in seropositivity (p = 0.000) was reported for buffalo
(64.8%) as opposed to other wild animal species tested (17.8%). Different levels of exposure to the FMDV resulted for
each of the buffalo subspecies sampled (p = 0.031): 68.4%, 50.0% and 0% for Nile Buffalo, West African Buffalo and African
Forest Buffalo, respectively. The characterisation of the FMDV serotypes tested for buffalo found presence of antibodies
against all the six FMDV serotypes tested, although high estimates for type O and SAT 3 were reported for Central Africa.
Different patterns of reaction to the six FMDV serotypes tested were recorded, from sera only positive for a single
serotype to multiple reactivities. The results confirmed that FMDV circulates in wild ruminants populating both West and
Central Africa rangelands and in particular in buffalo, also suggesting that multiple FMDV serotypes might be involved
with type O, SAT 2 and SAT 1 being dominant. Differences in serotype and spill-over risk between wildlife and livestock
likely reflect regional geography, historical circulation and differing trade and livestock systems.Introduction
Foot-and-mouth disease (FMD) is an economically dev-
astating disease of intensive livestock farming and high
production animals, caused by a virus member of the
Apthovirus genus within the Picornaviridae family, and
characterised by an acute and highly contagious vesicu-
lar disease which can develop into persistent infection.
Vesicular lesions resulting from FMD infection are
mainly found in tongue, lips and feet but in some cases
lesions also can occur in snout, muzzle, teats, skin and
rumen. The disease is characterised by a very short incu-
bation period and high level of virus excretion, particu-
larly in pigs [1]. In wildlife, the FMD pathogenesis varies* Correspondence: a.di-nardo.1@research.gla.ac.uk
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fection, making the diagnosis difficult either because the
variability in the severity of presenting clinical signs is
greater than in domestic livestock or because it tends to
be subclinical for the particular species/virus combin-
ation [2,3]. The transmission dynamic of FMD in sub-
Saharan Africa is mainly driven by two epidemiological
cycles: one in which wildlife plays a significant role in
maintaining and spreading the disease to other suscep-
tible wild and/or domestic ruminants [4-6], whilst with
the second the virus is solely transmitted within domes-
tic populations and hence is independent of wildlife.
More than 70 wild animal species have been demon-
strated to be susceptible to the FMD virus (FMDV) ei-
ther by natural infection or by experimental challenge,
and on several occasions the virus has been isolated
from naturally infected animals [7]. Among these, Cape
buffalo (Syncerus caffer caffer) has been clearly shown toticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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Southern African Territories (SAT) FMDV serotypes
[8-10], and in populations of Cape buffalo the virus has
been estimated to persist for 24 years or longer [11]. In-
fection in buffalo is subclinical and normally occurs in
calves as soon as maternal antibodies wane at 2–6
months of age. Acutely infected buffalo provide sources
of infection for other ruminants, both domestic and
wild, directly or through other species which have
contracted the infection from buffalo [5,6]. Although the
implication of the buffalo carriers in the epidemiology of
FMD has not been fully clarified, they have so far been
shown to transmit the disease while in that state
[4,8,12]. Phylogenetic relationships between SAT types
FMDV strains isolated from cattle and those carried by
buffalo have been reconstructed from different area of
southern Africa, proving that contacts between livestock
and buffalo regularly result in FMD outbreaks among
cattle [13,14]. Furthermore, available evidence based on
FMDV genome sequencing indicates that impala (Aepy-
ceros melampus) populations of the Kruger National
Park – South Africa, usually become infected with SAT
viruses derived from buffalo [5]. On occasions SAT line-
ages were demonstrated to have been transmitted first
from buffalo to impala and then from impala to cattle
[6,15]. Conceived as such, impala can provide a conduit
of infection between buffalo and livestock, acting as an
important intermediate between domestic and wild ru-
minants and as an amplifying host in the context of
FMD transmission dynamics [16]. Presence of antibodies
against the FMDV in several wildlife species has been
documented in studies conducted in different countries
of the African continent, but mainly within its eastern
and southern regions [16-18]. In addition, serological
screenings implemented in East African countries have
indicated potential infections of Cape buffalo with A and
O FMDV serotypes [19-23], although current data do
not support the primary role of buffalo and other wild
animal species in the transmission of those FMDV sero-
types generally occurring in domestic ruminants. This
represents an important pattern of the FMD transmis-
sion dynamics in large parts of sub-Saharan Africa that
still remains to be explained. Much is already known
about the role that Cape buffalo plays in the FMD epi-
demiology, largely from studies conducted in South and
East Africa; conversely, knowledge on the relationship
between FMDV and wildlife and/or other buffalo sub-
species that populate the rangelands of western and cen-
tral African regions has been less thorough. In order to
progress in the knowledge gap of the FMD epidemiology
in sub-Saharan Africa and to further investigate the role
of wildlife in the transmission of FMD, in this study the
prevalence of antibodies against the FMDV nonstructural
protein (NSP) and serological profiles of six out of theseven FMDV serotypes have been reconstructed from
wildlife samples collected from national parks and faunal
reserves of West and Central Africa. The aims of this
study were: firstly, to produce an overall picture of the
FMD prevalence in wildlife and mainly in buffalo subspe-
cies of West and Central Africa, also characterising risk
factors likely associated with the observed prevalence; sec-
ondly, to identify the FMDV serotypes potentially circulat-
ing in resident buffalo populations within the study area.
In addition, potential limitations of diagnostic testing pro-
cedures used have been evaluated.
Materials and methods
Study population
The study was undertaken on serum samples collected from
wild ruminants and pigs species during the African Wildlife
Veterinary Project [24], as part of the Pan-African Rinder-
pest Campaign (PARC) and the subsequent programme for
the Pan-African Control of Epizootics (PACE) implemented
in 34 countries across the African continent between 1986
and 2007. Wildlife species and sampling sites were selected
at the time according to susceptibility to the Rinderpest
(RP) virus, population biology (i.e. richness, gregarious
behaviour, and seasonal movements), interface between
livestock and wildlife, and their availability for veterin-
ary interventions. Sampling was performed using purpos-
ive sampling by immobilisation, opportunistic sampling by
cropping and/or hunting and during field investigations of
reported episodes of disease and mortality. From the whole
collection stored at the Centre de Coopération Internation-
ale en Recherche Agronomique pour le Développement
(CIRAD), Montpellier – France, 696 sera collected be-
tween 1999 and 2003 were selected as representative of
wildlife populations present in West and Central Africa
(Table 1; Figure 1). In addition, further 19 samples col-
lected from cattle within the transfrontier area of the
Central African Republic and Chad were included for
comparative purpose. Extracted aliquots were sent to The
Pirbright Institute, Pirbright – United Kingdom (UK), for
diagnostic testing.
Testing methodology
The sample collection was initially screened for antibodies
against the highly conserved NSP of the FMDV using the
PrioCHECK® FMDV NS Enzyme-Linked Immunosorbent
Assay (ELISA) test kit (Prionics AG, Switzerland), accord-
ing to the manufacturer protocol [25]. Specifically, a posi-
tive result was considered with a Percentage of Inhibition
(PI) value of ≥50, whereas a strong positive result was set
at a PI value of ≥70. Subsequently, the NS ELISA positive
reactive sera were further assessed using the Solid Phase
Competition ELISA (SPCE) in-house test developed at
The Pirbright Institute – UK [26,27], thus enabling the
qualitative and quantitative characterisation of the specific
Table 1 Wildlife samples tested allocated by region, country and species of collection.
Region Country No. Buffalo Samples No. Other Wildlife TOT
West Africa Benin 18 11 29
Burkina Faso 5 30 35
Nigeria 1 7 8
TOT 24 48 72
Central Africa Cameroun - 2 2
Central African Republic 81 247 328
Chad 53 203 256
Democratic Republic of Congo 34 - 34
Gabon 4 - 4
TOT 172 452 624
TOT 196 500 696†
†Not including the 19 samples collected from cattle.
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C, SAT 1, SAT 2 and SAT 3) and, therefore, the FMDV
serotyping profile of each of the serotypes present in
Africa at the time of the sampling. The cut-off for the SPCE
was set at a PI value of ≥50 for serotypes A, O and C,Figure 1 Geographical locations of the wildlife samples selected by s
genus sourced and adapted from [68].whilst a value of ≥40 PI was set for SATs serotypes [26].
Since the SPCE has not been validated for testing wildlife
sera, the data were further reassessed increasing the cut-
off to a value of ≥60 PI for serotypes A, O and C, and of
≥50 PI for SATs serotypes to account for an unpredictedpecies. Distributional extents of buffalo subspecies of the Syncerus
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set as the mean of the single negative response of each
serotype +5SD as estimated from the original validation
data [26]. According to the above defined thresholds, a
strong positive response was thus considered at either a PI
value of ≥70 or ≥80. Results from the SPCE were con-
firmed selecting a random sub-sample of the resulting
SPCE positive reactive sera by Virus Neutralization Test
(VNT), as prescribed by the World Organisation for Ani-
mal Health [28], and using the O1 Manisa, A22 Iraq 24/64,
C Phi 7/84, SAT 1 105, SAT 2 Eritrea, SAT 3 309 FMDV
strains. Cut-off for positivity with the VNT was set at a
titre of ≥1:45, whereas a titre of ≤1:11 and >1:11 but ≤1:32
were considered as negative and inconclusive, respectively.
Data analysis
The original database stored at the CIRAD and consisting
of information collected through paper forms during the
field campaigns was manipulated and inspected for miss-
ing and/or illogical data entries and completed and/or cor-
rected whenever possible. The ELISA results were stored
in an Access 2010 (Microsoft Corporation) database along
with associated metadata, such as geographical location
and GPS coordinates, national park and date of collection,
species and age. Statistical analyses were performed in R
3.1.2 [29], where confidence intervals were calculated
using the Agresti-Coull estimation of binomial propor-
tions [30]. Univariate analysis was carried out by the
Adjusted-Wald test, considering the effect of species, age,
year of sampling, location and park area on FMD sero-
prevalence [31]. All statistically significant variables
(p < 0.05 two-sided) in the univariate analysis were further
assessed by a generalised linear model (GLM) with a logit
function using a stepwise selection approach, in order to
characterise potential risk factors associated with the ob-
served FMD seroprevalence. The probability of FMD sero-
prevalence μ was then calculated by back-transforming
the estimated logit values g(x) as μ ¼ eg xð Þ1þeg xð Þ [32] and then
introduced in a geospatial analysis environment using Arc-
GIS 10.2.2 (Environmental System Research Institute,
Inc.) to produce a kernel smoothed intensity map of the
predicted FMD prevalence [33]. Pairwise correlation ana-
lysis based on the Pearson’s product–moment coefficient
(ρ) was undertaken on all possible combinations of PI esti-
mates resulted from the SPCE testing [34], where missing
data were treated as pairwise deletions.
Results
The distributions of PI values resulted from the NS ELISA
test for all the wildlife species (A) and for the buffalo sam-
ples only (B) are plotted in Figure 2. The 50th percentile
for all species was reported as 34.2 PI (95%CI 32.0 – 36.3),
different from the buffalo distribution that returned avalue of 62.0 PI (95%CI 55.1 – 66.8). This figure would re-
flect a defined distinction between the seronegative
(mainly non-buffalo species) and the seropositive (mainly
buffalo) populations, confirmed by the bimodal distribu-
tion found for all species and the left-skewed distribution
for the buffalo only. In addition, a total of 39 out of 89
(43.8%) positive samples for the non-buffalo species were
found having a PI value of ≥70 in contrast with the 61.4%
(78/127) estimated for the buffalo population. Thirteen
out of 19 samples (68.4%) tested positive for cattle, con-
firming potential previous exposure of domestic livestock
to the FMD; 84.6% (11/13) of those were returning PI
values of ≥70.
FMD seroprevalence in wildlife species: descriptive and
univariate analyses
The NSP testing of the non-buffalo wildlife reported FMD
positivity in 89 out of 500 samples (17.8%, 95%CI 14.7% –
21.4%), extracted from 16/27 species (59.3%). Among all
the wildlife species assessed, presence of antibodies were
found in individuals belonging to the Alcelaphinae (8.0%),
Antilopinae (2.1%), Bovinae (14.3%), Cephalophinae
(23.5%), Hippotraginae (7.1%), and Reduncinae (27.2%)
sub-families (Bovidae family, 18.4%), and for species be-
longing to the Suidae family (11.6%). Bohor Reedbuck
(Redunca redunca) (66.8%), Defassa Waterbuck (Kobus
ellipsiprymnus unctuosus) (63.2%), Red-Flanked Duiker
(Cephalophus rufilatus) (60.0%), Giant Eland (Taurotragus
derbianus) (21.4%) and Topi (Damaliscus korrigum jimela)
(21.4%) were the wild ruminants reporting high levels of
FMD seropositivity (Table 2). The only sample collected
from hippopotami and tested positive to the NS ELISA
(PI = 53) should be regarded as a false positive response to
the NS ELISA test, recalling that previous studies con-
ducted in the Kruger National Park failed to detect anti-
bodies against the FMDV in this species [2].
Effect of the region of collection was found to be
of statistical significance on seroprevalence estimates
(p = 0.003), where 19% of samples tested positive for Central
Africa whilst presence of antibodies were detected in
only few samples collected in West Africa (3/48). Filter-
ing the results by country of origin, a high FMD preva-
lence was estimated in samples obtained from Chad
(23.1%), although these data were obtained from mostly
a single national park (Zakouma National Park), thus
likely reflecting local conditions.
FMD seroprevalence in buffalo subspecies: descriptive
and univariate analyses
In total, 127 out of 196 tested positive for FMD (64.8%,
95%CI 57.9% – 71.1%). According to the subspecies of
the Syncerus genus, a high level of NSP antibodies was
reported in both Nile Buffalo (Syncerus caffer aequinoc-
talis) (68.4%) and West African Buffalo (Syncerus caffer
Figure 2 Histogram and kernel density plots of the NS ELISA percentage of inhibition values estimated for the complete dataset (A) and for
buffalo only (B). Red dash-dot line sets the cut-off point (PI = 50).
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ples were tested (0/4), no FMDV reactive sera were
found for African Forest Buffalo (Syncerus caffer nanus).
The difference in seroprevalence observed between each
of the buffalo sub-species was reported to be significant
(p = 0.031).The age mean of FMD seropositive individuals was es-
timated to be 9.1 ± 5.2 years with high FMD prevalence
values described in those animals aged between 2 and
10 years. However, no effect (p = 0.542) of age on the
FMD seropositivity levels extracted from each of the cat-
egories was observed (Table 3), even though sub-adult
Table 2 Observed prevalence of FMDV NSP antibodies reported for all the wildlife species tested.
Specie No Positive/TOT Observed seroprevalence 95% CI
African Bush Elephant (Loxodonta Africana) 0/1 0% -
African Forest Buffalo (Syncerus caffer nanus) 0/4 0% -
Blue Duiker (Philantomba monticola) 1/5 20.0% 2.0% - 64.0%
Bohor Reedbuck (Redunca redunca) 4/6 66.7% 29.6% - 90.7%
Bongo (Tragelaphus eurycerus) 0/2 0% -
Buffon’s Kob (Kobus kob) 24/172 13.9% 9.5% - 20.0%
Bush Duiker (Sylvicapra grimmia) 0/5 0% -
Bushbuck (Tragelaphus scriptus) 2/15 13.3% 2.5% - 39.1%
Common Warthog (Phacochoerus africanus) 4/29 13.8% 4.9% - 31.2%
Defassa Waterbuck (Kobus ellipsiprymnus unctuosus) 36/57 63.2% 50.1% - 74.5%
Dorcas Gazelle (Gazella dorcas) 0/40 0% -
Giant Eland (Taurotragus derbianus) 3/14 21.4% 6.8% - 48.3%
Giant Forest Hog (Hylochoeurs meinertzhageni) 0/1 0% -
Greater Kudu (Tragelaphus strepsiceros) 0/4 0% -
Hartebeest (Alcelaphus buselaphus) 1/20 5.0% 0% - 25.4%
Hippopotamus (Hippopotamus amphibious) 1/1 100% -
Kordofan Giraffe (Giraffa camelopardis antiquorum) 0/5 0% -
Lelwel Hartebeest (Alcelaphus buselaphus lelwel) 2/40 5.0% 0.5% - 17.4%
Nile Buffalo (Syncerus caffer aequinoctialis) 115/168 68.4% 61.1% - 75.0%
Nolan Warthog (Phacochoerus africanus africanus) 0/7 0% -
Oribi (Ourebia ourebi) 1/7 14.3% 0.5% - 53.3%
Red River Hog (Potamochoerus porcus) 1/6 16.7% 1.1% - 58.2%
Red-Flanked Duiker (Cephalophus rufilatus) 3/5 60.0% 22.9% - 88.4%
Red-Fronted Gazelle (Eudorcas rufifrons) 0/1 0% -
Roan Antelope (Hippotragus equinus) 2/28 7.1% 0.9% - 23.7%
Tiang (Damaliscus korrigum korrigum) 1/5 20.0% 2.0% - 64.0%
Topi (Damaliscus korrigum jimela) 3/14 21.4% 6.8% - 48.3%
West African Buffalo (Syncerus caffer brachyceros) 12/24 50.0% 31.4% - 68.6%
Western Hartebeest (Alcelaphus buselaphus major) 0/8 0% -
Yellow-Backed Duiker (Cephalophus silvicultur) 0/2 0% -
TOT Buffalo 127/196 64.8% 57.9% - 71.1%
TOT Other Wildlife 89/500 17.8% 14.7% - 21.4%
TOT Cattle 13/19 68.4% 45.8% - 84.8%
Adjusted-Wald test F(29, 667) = 10.06 (p = 0.000).
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prevalence and narrow interquartile range, which did
not include PI values below the cut-off point. No signifi-
cant difference between sexes was observed (p = 0.23).
Differences in seroprevalence estimates between sam-
pling years were found to be statistically significant
(p = 0.019). Overall, high level of FMD prevalence was
reported in samples collected during 1999 (68.2%) and
2002 (79.0%), although observing a higher seropreva-
lence for West Africa in samples collected in 2000(80.0%) as opposed to the seroprevalence (83.9%) re-
ported for Central Africa in 2002.
No significant difference (p = 0.115) resulted for the
regional prevalence distribution of FMD. Within each
region, high FMD seroprevalence was found in Burkina
Faso (80.0%) for West Africa, and in the Democratic
Republic of Congo (97.1%) and Central Africa Republic
(64.2%) for Central Africa (Table 3).
Considering the area of origin, presence of high levels
of antibodies against the NSPs was reported in those
Table 3 Observed prevalence of FMDV NSP antibodies reported for all the buffalo subspecies tested and filtered by
age, year, country and park of collection.
No Positive/TOT Observed seroprevalence 95% CI
Age Group Calf (≤6 m) 1/1 100% -
Juvenile (>6 m ≤2ys) 3/5 60.0% 22.9% - 88.4%
Sub-adult (>2ys ≤5ys) 36/51 70.6% 56.9% - 81.4%
Adult (>5ys) 78/125 62.4% 53.6% - 70.4%
Year 1999 30/44 68.2% 53.4% - 80.1%
2000 29/55 52.7% 39.8% - 65.3%
2001 13/22 59.1% 38.7% - 76.8%
2002 49/62 79.0% 67.2% - 87.4%
2003 6/13 46.1% 23.2% - 70.9%
Subspecie Nile Buffalo 115/168 68.4% 61.1% - 75.0%
West African Buffalo 12/24 50.0% 31.4% - 68.6%
African Forest Buffalo 0/4 0% -
Country Benin 8/18 44.4% 24.5% - 66.3%
Burkina Faso 4/5 80.0% 36.0% - 98.0%
Nigeria 0/1 0% -
West Africa 12/24 50.0% 31.4% - 68.6%
Central African Republic 52/81 64.2% 53.3% - 73.8%
Chad 30/53 56.6% 43.3% - 69.1%
Democratic Republic of Congo 33/34 97.1% 83.8% - 100%
Gabon 0/4 0% -
Central Africa 115/172 66.9% 59.5% - 73.5%
Park Pendjari National Park 8/18 44.4% 24.5% - 66.3%
Pama Reserve 3/3 100% -
Arly National Park 1/2 50.0% 9.4% - 90.5%
Borgu Game Park 0/1 0% -
Manovo-Gounda St. Floris National Park 15/19 78.9% 56.1% - 92.0%
Zemongo Faunal Reserve 6/7 85.7% 46.6% - 99.5%
Bamingui-Bagoran National Park 3/6 50.0% 18.8% - 81.2%
Zakouma National Park 22/41 53.7% 38.7% - 67.9%
Garamba National Park 33/34 97.1% 83.8% - 100%
Loango National Park 0/4 0% -
Adjusted-Wald test for age group F(3, 178) = 0.72 (p = 0.542).
Adjusted-Wald test for year F(4, 192) = 3.03 (p = 0.019).
Adjusted-Wald test for subspecie F(2, 194) = 3.52 (p = 0.031).
Adjusted-Wald test for country F(6, 190) = 6.62 (p = 0.000).
Adjusted-Wald test for region F(1, 195) = 2.51 (p = 0.115).
Adjusted-Wald test for park F(9, 126) = 5.27 (p = 0.000).
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Park (97.1%) of the Democratic Republic of Congo, the
Zemongo Reserve (85.7%) and the Manovo-Gounda St.
Floris National Park (78.9%) of the Central African
Republic (Table 3).
FMD spatial distribution in buffalo
According to the GLM analysis (Table 4), five main ef-
fect variables had statistically detectable association withthe FMD positive status to the NS ELISA test observed
for buffalo samples. Increased risk in the probability of
FMD seropositivity was associated with the longitude
(OR = 1.14, p = 0.011) of the sample locations, whereas a
decrease in risk was reported according to the latitude
(OR = 0.79, p = 0.000), year (OR = 0.72, p = 0.000) and
park area (OR = 0.68, p = 0.009) variables entered in the
model. The kernel smoothed intensity map produced
using the predicted FMD prevalence is shown in Figure 5.
Table 4 Generalised linear model (logit link) reporting the ORs with corresponding 95% CI for risk factors associated
with the FMD seroprevalence reported for all the buffalo subspecies tested.
β [95%CI] SE Z p Odds Ratio [95%CI]
Intercept 4.11 [1.57 – 6.66] 1.23 3.16 0.002 -
Park (Km2) −0.38 [−0.67 – −0.97] 0.15 −2.63 0.009 0.68 [0.51 – 0.91]
Longitude 0.13 [0.03 – 0.23] 0.05 2.53 0.011 1.14 [1.03 – 1.26]
Latitude −0.23 [−0.37 – −0.10] 0.07 −3.50 0.000 0.79 [0.69 – 0.9]
Year −0.32 [−0.48 – −0.17] 0.08 −4.10 0.000 0.72 [0.62 – 0.84]
Age 0.01 [0 – 0.01] 0.002 4.31 0.000 1.01 [1 – 1.01]
log-likelihood = −479.58; AIC = 973.17.
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ulations sampled, as predicted by the model, are located
mainly in the bordering areas between south-west Chad
and north-west Central African Republic, and in the
north-east Democratic Republic of Congo that borders
with South Sudan. This spatial range overlaps with the ex-
tent of the Aouk and Zakouma National Parks and the
Aouk Aoukale Faunal Reserve in Chad, the Manovo-
Gounda St. Floris and Bamingui-Bangoran National Parks
in the Central African Republic. The Manouvo-Gounda
St. Floris and the Zakouma National Parks constitute the
same ecological area and, as evidenced by the model pre-
diction and the prevalence reported, it is likely to be
regarded as high risk of FMD.FMDV serotyping profile in buffalo: descriptive and
correlation analyses
The overall results from the SPCE analysis of buffalo
samples showed presence of antibodies against all the 6
FMDV serotypes tested (Figure 3), with high levels esti-
mated for O (82.3%), SAT 2 (81.9%) and SAT 1 (73.2%)
serotypes (Table 5). Increasing the cut-off as described
in the methodology section did not largely change the
seroprevalence patterns found for O, SAT 1 and SAT 2
FMDV serotypes, differently from the A, C and SAT 3
seropositivities which were reduced to the order of 50%.
In addition, 41 out of 102 positive samples (40.2%), 44/
104 (42.3%) and 19/93 (20.4%) returned PI values ≥80
for type O, SAT 2 and SAT 1, respectively.
Interestingly, the pattern of FMD prevalence for each
of the 6 serotypes tested was shaped differently accord-
ing to the region of collection. Although high level of
antibody responses against both SAT 1 and SAT 2
FMDV serotypes were recorded for both West and Cen-
tral Africa, higher prevalence of type O, C and SAT 3
were found in samples collected from Central African
countries. Moreover, considering the distribution of PI
values returned for each of the 6 serotypes by region
(Figure 3), the third quartile (Q3) of type A, O, SAT 3
and to some extent of C results obtained for the WestAfrica samples was set below the threshold values and the
data distributions of type A and O were largely right-
skewed (with most of the data lying below the cut-off
points), in contrast with what reported for Central Africa.
Different patterns of reaction to the 6 FMDV serotypes
tested were recorded, from sera only positive for a single
serotype to multiple reactivities. A number of sera with
the highest serotype-specific responses (i.e. highest PI
values) were identified for type O (16.7%, 2/12), C
(16.7%, 2/12) and SAT 2 (58.3%, 7/12) in samples col-
lected from West Africa, and for type A (2.6%, 3/115), O
(47.8%, 55/115), C (5.2%, 6/115), SAT 1 (14.8%, 17/115),
SAT 2 (27.0%, 31/115) in those retrieved from Central
Africa (Table 6). No sera with the highest serotype-specific
response for SAT 3 were reported, even though PI values
of up to 79 and 87 were estimated from samples of West
and Central Africa, respectively. The potential cross-
reaction between pairs of serotypes tested was then
assessed computing the pairwise correlation matrix of
continuous data (PI values) for all the samples analysed
(Figure 4). Statistically significant correlations (p = 0.000)
with high ρ coefficients were reported for the A–SAT 1
(0.66), A–SAT 3 (0.61), SAT 1–SAT 3 (0.70), C–SAT 3
(0.67) and C–SAT 2 (0.54) pairs. No correlation was found
between O and any of the other FMDV serotypes tested
(ρ≤ 0.1; p > 0.05). The random sample (n = 43) extracted
from the SPCE positive data was confirmed by the VNT
test, which reported positive results at the highest titre of
1:90, 1:178, 1:256, 1:1024 and 1:355 for O, C, SAT 1, SAT
2 and SAT 3 FMDV serotypes, respectively. Inconclusive
results were obtained for type A (titre of 1:22).Discussion
This study reports the FMD serological profile extracted
from wildlife populations inhabiting the rangelands of
West and Central Africa. The results confirm that
FMDV circulates within wildlife-livestock ecosystems
present in the study regions and in particular in buffalo
subspecies, also suggesting that multiple FMDV sero-
types may be involved with type O, SAT 2 and SAT 1
Figure 3 Box plot of the SPCE percentage of inhibition values for buffalo samples according to each of the FMDV serotypes tested
[Overall (A) and regional (B) data]. Cut-off was set at either a PI value of ≥50 or ≥60 for A, O and C serotypes, and at either a PI value of ≥40
or ≥50 for SATs serotypes (red dotted lines) outlier.
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for each of the serotypes tested was reported between
West and Central Africa, with high levels of serotype-
specific antibodies against type O, C and SAT 3 found in
buffalo samples sourced from Central Africa. These re-
sults would indicate a distinct geographical extent ofFMDV serotypes circulating in buffalo populations
present in West and Central Africa, which might be as-
sociated with transboundary movements of FMDV line-
ages and, thus, in line with what has been historically
described for the FMDV pools 4 and 5 [35,36]. Although
historical data of FMDV isolates recovered from buffalo
Figure 4 Scatterplot matrix of the pairwise correlation analysis estimated between PI values obtained from buffalo samples tested for
each of the FMDV serotypes by SPCE. Variables are reordered and coloured according to the returned Pearson correlation values [blue (ρ ≤ 0.3);
yellow (0.3 >ρ ≤ 0.5); red (ρ ≥ 0.5)], where higher correlated variables are plot near the diagonal.
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the sampling were generally not available, the here de-
fined FMD distribution in wild ruminants of West and
Central Africa might largely contribute in providing a
clearer picture of the FMD burden in those largely un-
studied regions of sub-Saharan Africa. The reported out-
breaks affecting livestock of West Africa since 2000
were caused by FMDV types A, O and SAT 2 circulating
in Benin (O and A in 2010), Burkina Faso (O in 2002),
Cameroon (O in 2000 and 2005; A and SAT 2 in 2000,2005 and 2012–13), Mali (O in 2004–05; A in 2004 and
2006), Mauritania (O in 2000–01; A in 2006), Niger (O
in 2001 and 2005; SAT 2 in 2007–08 and 2011–12),
Senegal (O in 2001 and 2006; SAT 2 in 2009), Togo (O
in 2004–05; A in 2005) [37-43]. From 1970, reports of
FMD activities in Central Africa were only available for
types A and SAT 2 in Chad (1973 and 1972, respect-
ively) and for the Democratic Republic of Congo (O in
2006 and 2010; A in 2011; SAT 2 in 1974, 1979 and
1982) [44]. FMDV type C has never been reported in
Table 5 Observed prevalence of serotype-specific FMDV antibodies reported for all the buffalo subspecies tested as
overall result and by region of collection.
Serotype No Positive/TOT Observed seroprevalence† 95%CI
West Africa A 6/12 50.0% 25.4% - 74.6%
O 6/12 50.0% 25.4% - 74.6%
C 7/12 58.3% 31.9% - 80.7%
SAT 1 8/12 66.7% 38.8% - 86.4%
SAT 2 9/12 75.0% 46.1% - 91.7%
SAT 3 3/12 25.0% 8.3% - 53.8%
Central Africa A 50/115 43.4% 34.8% - 52.6%
O 96/112 85.7% 77.9% - 91.1%
C 77/115 67.0% 57.9% - 74.9%
SAT 1 85/115 73.9% 65.2% - 81.1%
SAT 2 95/115 82.6% 74.6% - 88.5%
SAT 3 56/115 48.7% 39.7% - 57.7%
TOT A 56/127 44.1% 35.8% - 52.8%
O 102/124 82.3% 74.5% - 88.0%
C 84/127 66.1% 57.5% - 73.8%
SAT 1 93/127 73.2% 64.9% - 80.2%
SAT 2 104/127 81.9% 74.2% - 87.7%
SAT 3 59/127 46.5% 38.0% - 55.1%
†Cut-off values set as ≥50 for A, O and C serotypes, and ≥40 for SATs serotypes.
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this FMDV serotype was only confined to East Africa in
Kenya (1957–2004), Ethiopia (1957–1983) and Uganda
(1970–71), from when it seems to have been extinct
[45]. A very striking results provided from this study is
the relatively high proportion (84/127) of serotype C
positive sera, although with only 6 producing very high
PI values. This may either indicate a potential cross-
reactivity with other serotypes (high correlations were
found between C and both SAT 2 and SAT 3) or that
serotype C may have been circulating without being de-
tected, with the latter less plausible. The SAT 3 serotype
has been mainly documented in Southern African coun-
tries with occasional isolations in Uganda (1970 and 1997)
from samples collected from Cape Buffalo in the southernTable 6 Number of buffalo sera with highest serotype-specifi
serotype tested positive on the SPCE by country of collection
A O
Benin 0/8 [60] 2/8 [73]
Burkina Faso 0/4 [63] 0/4 [67]
West Africa 0/12 [63] 2/12 [73]
Central African Republic 1/52 [80] 22/52 [95]
Chad 2/30 [75] 9/30 [85]
Democratic Republic of Congo 0/33 [82] 24/33 [108]
Central Africa 3/115 [82] 55/115 [108]part of the Queen Elizabeth National Park [46,47]. In 2013,
FMDV SAT 3 was isolated from a sub-clinically (or persist-
ently) infected Ankole calf at Nyakatonzi (Kasese District),
in close proximity to the northern part of the Queen Eliza-
beth National Park [48]. These finding may indicate that
this serotype is also potentially maintained in buffalo popu-
lations present in wildlife ecosystems of Eastern Africa [17].
The SPCE test used in this study for the qualitative
and quantitative detection of antibodies against the
FMDV serotypes has previously proven to be more ro-
bust and specific, and equally sensitive to the Liquid
Phase Blocking ELISA (LPBE) [26], but not totally un-
affected by serological cross-reactivity between FMDV
serotypes, thus representing a valid, easy and fast to
process alternative to the VNT. It should be noted thatc FMDV antibodies response [highest PI value] per
.
C SAT 1 SAT 2 SAT 3
2/8 [92] 0/8 [87] 3/8 [92] 0/8 [79]
0/4 [71] 0/4 [76] 4/4 [99] 0/4 [40]
2/12 [92] 0/12 [87] 7/12 [99] 0/12 [79]
4/52 [85] 11/52 [98] 13/52 [93] 0/52 [87]
2/30 [74] 2/30 [87] 13/30 [96] 0/30 [81]
0/33 [88] 4/33 [97] 5/33 [90] 0/33 [83]
6/115 [88] 17/115 [98] 31/115 [96] 0/115 [87]
Figure 5 Kernel density map of the predicted probability μ of FMD seropositivity in buffalo as estimated from the generalised linear
model (logit link). Geographical extent of African wildlife protected areas are sourced and adapted from [69].
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but only for cattle, pigs and sheep [26,27], and this might
have an impact on the results here generated. However,
the selection of higher cut-off values for the SPCE positiv-
ity threshold, aiming at reducing a potential false positive
response, did not change the seroprevalence figures here
reported and, furthermore, several buffalo samples
returned PI values of ≥80 thus indicating presence of high
antibody levels. In addition, a random sample of the posi-
tive sera generated from the SPCE has been confirmed by
VNT testing. The mismatch between the strains used for
the VNT testing and antibodies present in the sera might
have an impact on the results obtained. However, the pre-
cise selection of an appropriate test antigen would not be
possible when testing sera of unknown status and, there-
fore, it has been assumed that antigenic differences were
limited, with positive samples still producing high titres to
the specific strains than to the other serotypes. Although
correlations between serotype-specific responses have
been evaluated, the extent to which findings of individual
sera reactive to multiple serotypes is due to serological
cross-reactivity or multiple infections has not been entirelyruled out. However, subsequent multiple serotypes infec-
tions do occur and even simultaneous multiple infection
cannot be excluded. In a previous study it has been dem-
onstrated that buffalo carriers are refractory to reinfection
with the same strain of virus [49,50] thus supporting the
hypothesis of potential co-infections and/or subsequent
infections with more than one serotypes. Although the re-
sults here reported suggest infections of buffalo subspecies
with different FMDV serotypes, there is little published on
non-SAT serotypes in buffalo population [19-23], with no
evidences supporting the hypothesis that domestic types
of FMDV has come from buffalo as carrier. In a recent
study, the phylogenetic descent of the SAT 2 serotype
across the entire African continent was regarded to have
originated from a FMDV ancestor formerly infecting Cape
buffalo, also evaluating that interspecies virus transitions
might occur between Cape buffalo and cattle, and vice
versa [51]. Although this would support the hypothesis
of FMDV shifting between wildlife and livestock, the
incomplete and biased nature of the analysed data
could potentially derive confounding results. Neverthe-
less, genetic and epidemiological analyses have clearly
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tween SATs viruses infecting buffalo and other wild
species (e.g. Impala) to those causing outbreaks in cat-
tle [16,52,53]. In addition, a field study conducted in
Ethiopia found significant association between cattle
exposed to FMDV and their contact history with wild-
life [54], whilst a recent study conducted at the periph-
ery of protected areas in Zimbabwe indicates that
interactions between livestock and buffalo populations
can account for FMD primary outbreaks [55]. Besides
studies based on serological investigations, to what ex-
tent types of FMDV prevalent in domestic ruminants
infect wildlife is unknown; hence, until this issue is in-
vestigated thoroughly it will constitute a major defi-
ciency in understanding the epidemiology of FMD in
large parts of sub-Saharan Africa. Therefore, further
field studies are warranted to collect clinical samples, in
order to enable the genome characterisation of FMDV
lineages circulating within wild animal species of West
and Central Africa and to confirm if FMDV serotypes nor-
mally present in domestic livestock are really mixing with
buffalo and, thus, eventually become established in those
populations. However, it should be noticed that two
significant buffalo populations at present exist in West
and Central Africa, which are susceptible to share cattle
grounds (Figures 1 and 5): the W-Arly-Pendjari (WAP)
Parks Complex (tranfrontier area shared between Benin,
Burkina Faso and Niger, which hosts around 10000+ buf-
falo) and the Zakouma National Park (which hosts around
7000+ buffalo). This geographic distribution of buffalo
would therefore likely contribute to reduce the mixing be-
tween buffalo and livestock thus decreasing the risk of
FMD transmission.
Wild animal species already reported to be susceptible
to the FMDV [7] were confirmed in this study. In
addition, presence of antibodies against the FMDV has
not been previously described in Buffon’s Kob (Kobus
kob) and Oribi (Ourebia ourebi), therefore increasing the
number of wild ruminant species reported to be suscep-
tible to FMD infection in sub-Saharan Africa. In addition,
the FMD prevalence found in non-buffalo species of West
and Central Africa is higher than what has previously been
reported in other studies targeting wildlife ecosystems of
Eastern Africa and Zimbabwe [17,18,56]. The high FMD
prevalence found in Bohor Reedbuck and Waterbuck
might reflect their ecology and living ecosystem: in fact
they are dependent on water with living habitats close to
water sources, which might indicate a link between FMD
transmission within and between wildlife species (and/or
between domestic and wild animals) when congregating at
watering points. This study provides the first evidence of
FMDV exposure in subspecies of the Syncerus genus other
than the Cape buffalo [7], thus accounting for their poten-
tial role in the epidemiology of FMD outside the livinghabitat of Cape buffalo in Eastern and Southern African
regions. Although the predicted spatial distribution of
FMD in buffalo might reflect the epidemiological status at
the time of the sampling, a generalisation to the current
situation might be expected since no effective control
measures have been implemented in recent years either in
West or Central African regions, and up-to-date data have
not been published. In addition, although accounting for
the extent of the protected areas present in West and
Central Africa, the predicted FMD spatial distribution was
not intended to resolve the landscape structure of the
study regions, and so this might cover areas where buffalo
ecological niches might be absent. Therefore, a more
extensive sampling frame would be required to provide a
more exhaustive indication of the spatial burden of FMD in
wildlife ecosystems of West and Central Africa. This initial
attempt would, nevertheless, provide useful information
to be linked for a broad scale strategic FMD monitoring
planning.
According to the buffalo subspecies tested, the FMD
prevalence found might reflect the different social
organization and population biology of each of the sub-
species considered. For example, the African forest buf-
falo herds are quite isolated, have a small animal density
(herd size of about 3–25 individuals) and move in a lim-
ited home-range (~2.3–8 km2) compared to the Cape
buffalo. In addition, they have a very secretive behaviour
and a limited distribution, mainly found in rainforest
ecosystem [57]. Savannah buffalo (West African and Nile
buffalo) more frequently split into smaller herds, herd-
switching is more common and they have a large home
range. This is opposed to Cape buffalo herds that are
more densely populated (e.g. mass herds can vary from
few hundreds up to several thousand individuals) and
engage in long-distance dispersal [58]. In a previous
study conducted in Cape buffalo population of East
Africa, a 67.7% of the total samples tested was reported
as FMD positive [17]. Therefore, this might indicate dif-
ferent patterns of FMD susceptibility across the different
buffalo subspecies that might be linked to the species
ecology, even though only four African forest buffalo
samples were available for testing. In fact, susceptibilities
to the FMDV of buffalo living in savannah habitat are
consistent across sub-species but African forest buffalo
might show a different epidemiology. On the other hand,
this could be a concurrent result of the host living habitat,
the social behaviour of each of the buffalo subspecies, and
the extent of the FMD geographical distribution (i.e. the
African forest buffalo samples were collected from Gabon,
in which FMD has never been reported in the periods
between 1996 and 2003 [59], and between 2006 and 2012
[60]). In addition, it should be noted that the African for-
est buffalo were darted in the Loango National Park where
the livestock presence is very low and especially absent
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buffalo and cattle besides the very low size of herds (<8
heads). From the model estimates, the odds of a buffalo
resulting FMD positive by NS ELISA is reduced by 0.98
for every 10 km2 increase in the park area. This would be
directly correlated with the density of buffalo population,
which might indicate that in large ecosystems herds tend
to be sparser, not overlapping their home ranges, and thus
diminishing the risk of transmitting and maintaining the
disease. In addition, the rainforest area of western and
central Africa represents a limiting factor for the spatial
and demographic expansion of buffalo herds (and live-
stock), as would be the case for African forest buffalo that
mainly inhabits forest clearings [61]. Figures indicate that
89.3% of rainforests is present in Central Africa, where the
Democratic Republic of Congo accounts for the largest
African lowland rainforest area (53.6%) [62]. However, the
FMD prevalence (97.1%) obtained from the Democratic
Republic of Congo was resulting from Nile buffalo sam-
ples collected in the Garamba National Park, which
mainly covers vast grass savannahs and woodlands. Fur-
thermore, density of buffalo population fluctuates accord-
ing to seasons, which tend to be reduced during the dry
season as at this time of the year the size of the area for
grazing and watering is really reduced compared to the
rainy season.
Direct contacts between buffalo and livestock seem
to be rare, with degrees of variability determined by
ecosystem structure and climatic cycles. It seems to be
more common in open habitats and with plains species
(e.g. during mass migration of wildebeest, topi, zebra
and gazelles as in the Mara-Serengeti ecosystem in East
Africa) and during the dry seasons, when water avail-
ability constrains animals to closely congregate thus in-
creasing the transmission likelihood of water-related
infections [63]; in fact, these are also the times of the
highest level of residency and density within protected
areas of both livestock and buffalo. In addition, it
should be noted that wildlife usually avoids livestock
and human contacts (i.e. at watering points or locations
with key forage resources) in a space-time fashion un-
less habituated. As FMD requires a relatively close con-
tact setting for interspecies transmission, the FMD
interface between wildlife and livestock should, there-
fore, not be seen as a direct physical interaction but as
an indirect contact (i.e. through soil, forage and water
contaminated by bodily discharge of infected animals),
which might be regarded as the most likely factor to be
associated with the risk of FMDV transfer from domes-
tic to wildlife species. Eventually, the spread of FMD
within the wildlife-domestic interface might be driven
by a complex interplay of risk factors, including bio-
physical and climatic features, ecological traits and hu-
man practices.The control of the wildlife-livestock interface in the
transmission of FMD has been only successfully applied in
South Africa at a considerable ecological and economic
cost [64,65] by the means of herds separation (e.g. strict
land-use policies, animal movement controls and fencing)
and buffer vaccination of livestock population around the
source of virus [66]. However, in countries where wildlife
populations are integrated with extensive nomadic and
semi-nomadic pastoralism, as would be the case for West
and Central Africa, the risk of FMD spread increases not
only for the difficulty in applying effective control mea-
sures (e.g. pastoralists usually rely on ethnoveterinary
practices [67] and move within and between countries in
an uncontrolled fashion), but also for the increase in the
land-use pressure and conflict between pastoralists and
wildlife competing for grazing and water resources. As
example, the St. Floris National Park, Central African
Republic, is boasting a large population of buffalo and is
a grazing and transhumance crossing land for the Fulani
pastoralist tribe. A 78.9% of FMD prevalence in Nile buf-
falo has been reported in this ecosystem, with high
serotype-positive responses against type O, SAT 1 and
SAT 2. The demographic growth, the expansion of cultiva-
tion (e.g. agro-pastoral systems), the development of local
governance on natural resources [65] and the reduction of
rangeland resources in Africa have indeed led to increased
sharing of resources between domestic and wildlife species
and hence the risk of diseases transmission. However, the
ecological processes driving the FMDV evolution and
transmission in the sub-Saharan African ecosystems still
remain poorly documented. In this context the nature of
the wildlife-livestock interface in pastoral landscapes and
its complex socio-ecological-economic interactions have
not been entirely studied and need to be thoroughly inves-
tigated. The importance and, at the same time, the diffi-
culties in controlling the FMD in the sub-Saharan Africa
relies on the unique diversity and numbers of the wild spe-
cies present and the explosive growth of the human popu-
lation, which consequently needs to create solutions that
would work for improving the agriculture standards, the
sanitary safety of livestock trade, the sustainable land use
and the biodiversity conservation of wildlife ecosystems.
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